Literature DB >> 27608972

Placental growth factor: What hematologists need to know.

Laura F Newell1, Shernan G Holtan2.   

Abstract

Although first identified in placenta, the angiogenic factor known as placental growth factor (PlGF) can be widely expressed in ischemic or damaged tissues. Recent studies have indicated that PlGF is a relevant factor in the pathobiology of blood diseases including hemoglobinopathies and hematologic malignancies. Therapies for such blood diseases may one day be based upon these and ongoing investigations into the role of PlGF in sickle cell disease, acute and chronic leukemias, and complications related to hematopoietic cell transplantation. In this review, we summarize recent studies regarding the potential role of PlGF in blood disorders and suggest avenues for future research.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Graft-versus-host disease; Hematopoietic cell transplantation; Leukemia; Placental growth factor; Sickle cell anemia

Mesh：

Substances：

Year:  2016        PMID： 27608972      PMCID： PMC5916812          DOI： 10.1016/j.blre.2016.08.004

Source DB:  PubMed          Journal:  Blood Rev        ISSN： 0268-960X            Impact factor:   8.250


  100 in total

1.  Airway hyperreactivity in children with sickle cell disease.

Authors:  M A Leong; C Dampier; L Varlotta; J L Allen
Journal:  J Pediatr       Date:  1997-08       Impact factor: 4.406

2.  Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

Authors:  R L Kendall; K A Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

3.  Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease.

Authors:  Kenneth I Ataga; Julia E Brittain; Susan K Jones; Ryan May; John Delaney; Dell Strayhorn; Payal Desai; Rupa Redding-Lallinger; Nigel S Key; Eugene P Orringer
Journal:  Br J Haematol       Date:  2011-01-11       Impact factor: 6.998

4.  Placenta growth factor activates monocytes and correlates with sickle cell disease severity.

Authors:  Natalya Perelman; Suresh K Selvaraj; Sandeep Batra; Lori R Luck; Anat Erdreich-Epstein; Thomas D Coates; Vijay K Kalra; Punam Malik
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

5.  Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation.

Authors:  Rohit Khurana; Lieve Moons; Shahida Shafi; Aernout Luttun; Désiré Collen; John F Martin; Peter Carmeliet; Ian C Zachary
Journal:  Circulation       Date:  2005-05-23       Impact factor: 29.690

6.  Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition.

Authors:  Bijan Keikhaei; Ali Reza Mohseni; Reza Norouzirad; Mastaneh Alinejadi; Somayeh Ghanbari; Fariba Shiravi; Ghasem Solgi
Journal:  Eur Cytokine Netw       Date:  2013-03       Impact factor: 2.737

Review 7.  The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.

Authors:  Robert P Hebbel; Raymond Osarogiagbon; Dhananjay Kaul
Journal:  Microcirculation       Date:  2004-03       Impact factor: 2.628

8.  Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells.

Authors:  Alan F List; Betty Glinsmann-Gibson; Chad Stadheim; Emmanuelle J Meuillet; William Bellamy; Garth Powis
Journal:  Exp Hematol       Date:  2004-06       Impact factor: 3.084

9.  Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy.

Authors:  C Lanaro; C F Franco-Penteado; D M Albuqueque; S T O Saad; N Conran; F F Costa
Journal:  J Leukoc Biol       Date:  2008-11-12       Impact factor: 4.962

10.  Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization.

Authors:  Beate Heissig; Shahin Rafii; Haruyo Akiyama; Yuichi Ohki; Yayoi Sato; Tejada Rafael; Zhenping Zhu; Daniel J Hicklin; Ko Okumura; Hideoki Ogawa; Zena Werb; Koichi Hattori
Journal:  J Exp Med       Date:  2005-09-12       Impact factor: 14.307
View more
  5 in total

Review 1.  Placenta growth factor mediated gene regulation in sickle cell disease.

Authors:  Vijay K Kalra; Shuxiao Zhang; Punam Malik; Stanley M Tahara
Journal:  Blood Rev       Date:  2017-08-16       Impact factor: 8.250

2.  CSF placental growth factor - a novel candidate biomarker of frontotemporal dementia.

Authors:  Oskar Hansson; Alexander F Santillo; Lieke H Meeter; Karin Nilsson; Maria Landqvist Waldö; Christer Nilsson; Kaj Blennow; John C van Swieten; Shorena Janelidze
Journal:  Ann Clin Transl Neurol       Date:  2019-03-29       Impact factor: 4.511

Review 3.  Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions.

Authors:  Agnieszka Dominiak; Beata Chełstowska; Wioletta Olejarz; Grażyna Nowicka
Journal:  Cancers (Basel)       Date:  2020-05-14       Impact factor: 6.639

4.  Prolactin (PRL), placenta growth factor (PIGF) and nerve growth factor receptor (NGFR) as biomarkers for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma (ESCC).

Authors:  Xiaohong Ai; Xiaoxi Zhu; Jianhong Zuo
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

5.  A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant.

Authors:  Sendhilnathan Ramalingam; Sharareh Siamakpour-Reihani; Lauren Bohannan; Yi Ren; Alexander Sibley; Jeff Sheng; Li Ma; Andrew B Nixon; Jing Lyu; Daniel C Parker; James Bain; Michael Muehlbauer; Olga Ilkayeva; Virginia Byers Kraus; Janet L Huebner; Thomas Spitzer; Jami Brown; Jonathan U Peled; Marcel van den Brink; Antonio Gomes; Taewoong Choi; Cristina Gasparetto; Mitchell Horwitz; Gwynn Long; Richard Lopez; David Rizzieri; Stefanie Sarantopoulos; Nelson Chao; Anthony D Sung
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.